Skip to main content
Northwestern University

Therapeutics

Click on each technology for a short description and access to the complete details in our online platform, Flintbox.

Technology Pipeline

Use the checkbox to filter by license availability:

Stage 1

New Targets
Available for license
2-Imidazoyl-Pyrimidine Scaffolds for nNOS inhibition 2014-101
Available for license
Anti Inflammatory Antibodies
Available for license
Bacterial NOS inhibitors
Available for license
Female Fertility Treatment
Available for license
G Protein Inhibitors for AF Treatment
Available for license
GLUT Antagonists: Cancer 1
Available for license
GLUT Antagonists: Cancer 2
Available for license
Human Melanoma
Available for license
Hydrogel Wound Dressing With Controlled Ion Release Properties
Available for license
Immunotherapy for Macular Degeneration
Available for license
MAPK Compounds CNS
Available for license
MLCK Inhibitors
Available for license
NOS: Neurodegeneration
Available for license
NOS Portfolio Inhibitors
Available for license
Pro-Drugs for Streptococcus
Available for license
Scar-Free Tissue Regeneration
Available for license
Screen for covalent drugs
Available for license
Sirtuin Inhibitors
Available for license
Soft Materials for Bioprinting
Available for license
TGFb Inhibitor Transgene
Available for license
Thermoresponsive Cell Adhesive Bioresorbable Dressing

Stage 2

Hit to Lead
Available for license
A4 Laminin Ab
Available for license
AMPA Receptor Antagonists for Neurologic Diseases
Available for license
CD154 Trimer Stabilization: Immunity
Available for license
Compounds against Nodal Pathway
Available for license
Compounds for CNS diseases
Available for license
Compounds for Neurologic Disorders
Available for license
Enzymatic Plaque Digestion
Available for license
Epstein-Barr Virus Inhibitors
Available for license
Flufenamic Acid for Chronic Pain
Available for license
HIV Therapeutics
Available for license
Ion Channel Manipulation: Parkinson's
Available for license
Maspin for Bone Disorders
Available for license
Megakaryocytic Leukemia Treatment
Available for license
p53 Reactivators
Available for license
Peptide Amphiphiles for Neurite Outgrowth
Available for license
Peptides for Cancer Treatment
Available for license
Peptides for PEDF
Exclusive License
Peptides: Immune tolerance
Available for license
Small molecule antiviral therapy
Available for license
Small Molecules against ALS
Available for license
Small Molecules against Hepatocellular Carcinoma
Available for license
Soft Materials for Bioprinting
Available for license
Stem Cell Signaling Molecules for Cancer Therapies
In Negotiations
Therapeutic Exosomes
Available for license
Topical Wound Treatment
Available for license
UTI Vaccine

Stage 3

Lead Optimization
Available for license
B Lactam Inhibitors I
Available for license
Bladder Regeneration
Available for license
Gene Silencing Enhancers
Available for license
Gene Therapy for Atrial Fibrillation
Available for license
Herpes Viruses for Vaccines
Available for license
Inflammation Modulator
Available for license
Kinase Inhibitors
Available for license
Malaria Prophylaxis
Available for license
Maspin Protein Mimics for Cancer Treatment
Available for license
Nanoparticulate Arsenic Platinum Drugs
Exclusive License
Neurodegenerative Disease Therapy
Exclusive License
Neuroprotective Therapeutics
Available for license
Small Molecules for Parkinson's Disease
Available for license
Triggered Release Arsenic for Cancer

Stage 4

Pre-Clinical Development
Available for license
Bone Marrow Derived Cells to Regenerate Bladder Tissue
Available for license
Cell Tolerance for Preventing Allograft Rejection
Exclusive License
Chronic Pelvic Pain Vaccine
Available for license
E. Coli Isolated from Human Prostate
Available for license
Glycosides for Cancer
Available for license
Medical Food
Available for license
Nanodiamonds for Imaging and Drug Delivery
Exclusive License
Numonafide for Cancer Treatment
Available for license
Peptide Vaccine for Lupus
Available for license
Preventing Scar Formation
Available for license
Preventing UTI Symptoms
Available for license
Proteosome Inhibitors for Steroid Sensitization
Exclusive License
Small Molecules CNS
Exclusive License
Spherical Nucleid Acids: Gene Regulation
Exclusive License
Tau Antibodies

Stage 5

Clinical Trials
Exclusive License
Antisense Molecules
Exclusive License
GLYX-13: Depression and Pain
Available for license
Isradipine: Parkinsons
Available for license
Lead Compounds For Neurodegeneration and Neuroinflammation
Exclusive License
Metalophile Technology ID and cancer
Available for license
Method to Control Dopaminergic Neuron Pacemaking
Exclusive License
Small Molecules for Tourettes Syndrome

Stage 6

Approval
Exclusive License
Lyrica: Fibromyalgia
Back to top